|
|
Volumn 8, Issue 8, 2009, Pages 604-
|
|
Immunotherapy shows promise in Phase III neuroblastoma trial.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GANGLIOSIDE;
GANGLIOSIDE, GD2;
MONOCLONAL ANTIBODY;
HUMAN;
IMMUNOLOGY;
IMMUNOTHERAPY;
METHODOLOGY;
MORTALITY;
NEUROBLASTOMA;
NOTE;
PHASE 3 CLINICAL TRIAL;
SURVIVAL RATE;
TREATMENT OUTCOME;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS, PHASE III AS TOPIC;
GANGLIOSIDES;
HUMANS;
IMMUNOTHERAPY;
NEUROBLASTOMA;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 69149096506
PISSN: None
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2951 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|